Furthermore, these markers achieved higher sensitivity and specificity for the diagnosis of CRC compared with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), and thus, they might constitute biomarkers for diagnosing patients with early-stage CRC [154]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.